Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP, is a Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. Additionally, she is the Associate Dean of Faculty Affairs and Programmatic Innovation and serves as Professor for the Center for Critical Care Nephrology. Aside from her academic appointments, Dr. Kane-Gill is a Critical Care Medication Safety Pharmacist at the University of Pittsburgh Medical Center in the Department of Pharmacy.
Dr. Kane-Gill received her Bachelor of Science degree in pharmacy from Wayne State University in Detroit, Michigan. She completed a pharmacy practice residency accredited by the American Society of Health-System Pharmacists at West Virginia University Hospital in Morgantown, West Virginia, and earned a Doctorate of Pharmacy degree from the University of Toledo in Toledo, Ohio. Dr. Kane-Gill then pursued her Master of Science degree in Pharmacy Administration with an emphasis on Pharmacoeconomics and Health Outcomes at The Ohio State University in Columbus, Ohio, and she completed a critical care fellowship at The Ohio State University. Furthermore, Dr. Kane-Gill completed a certification program in implementation science through the CTSI online training program at the University of California, San Francisco.
Dr. Kane-Gill’s interests focus on the assessment of clinical, economic and quality outcomes for critically ill patients. Her goal is to build a pharmacovigilance program to identify effective approaches for the detection, prevention, and management of medication errors and adverse drug events as to improve quality of care and patient safety. She led several pharmacoepidemiology evaluations that improved patient safety surveillance systems, prevented medication errors and adverse drug events (ADEs) and used health information technology (clinical decision support systems, telemedicine, simulation) to improve services. She applies implementation science strategies to ensure the adoption of evidence-based medication safety practices. Dr. Kane-Gill is a federally funded researcher serving as Principal Investigator (AHRQ, NIDDK) and Co-Investigator (AHRQ, NCCIH, NLM, Jewish Healthcare Foundation) on several research grants in this area of study.
Her work has been presented at several professional meetings with over 180 invited presentations and 200 abstract presentations. She has published more than 250 articles and book chapters related to critical care and patient safety. Her endeavors include editing published books on the use of high-risk intravenous medications in special patient populations and drug-induced complications in critically ill patients. She is on the editorial board for Critical Care Medicine and Annals of Pharmacotherapy. Dr. Kane-Gill is an active member of the American College of Clinical Pharmacy (ACCP), and Society of Critical Care Medicine (SCCM). She is a faculty member of the Research and Scholarship Academy of ACCP. In 2022, she held the elected position of President of the Executive Committee for the Society of Critical Care Medicine (SCCM), which is the decision-making body regarding the governance of SCCM. She is a fellow in the American College of Critical Care Medicine and the American College of Clinical Pharmacy.
2024 Society of Critical Care Medicine: Distinguished Service Award
2023 American College of Clinical Pharmacists (ACCP): Therapeutic Frontiers Lecture Award
2023 American Associate of Colleges of Pharmacy (AACP): Paul R. Dawson Award for Excellence in Patient Care Research
2023: American College of Clinical Pharmacy: Therapeutic Frontiers Lecture Award
2023 Expertscape: Expert in Acute Kidney Injury
2021 American Society of Health System Pharmacists: Literature Award for Sustained Contributions
2021 Expertscape: Expert in Medication Errors- top 1% of scholars in the world writing about Medication Errors over the past 10 years and acknowledged on World Patient Safety Day
2019 Pennsylvania Pharmacists Association: Excellence in Innovation Award
2019 West Virginia University Hospitals: Commitment to Pharmacy Excellence Award
2016 American Society of Health System Pharmacists: Residency Excellence Award (Preceptor)
2016 American Society of Health System Pharmacists: Award for Innovation in Pharmacy Practice
Complete publication list found at: https://www.ncbi.nlm.nih.gov/sites/myncbi/1fWktqSijXfkn/bibliography/51….
Selections from a list of over 200 peer-reviewed publications:
Yang L, Guo J, Kane-Gill SL, Gabriel N, Empey K, Suh K, Kirisci L, Hernandez I. Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis. Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70098. PMID: 39842818.
Mannis, MM, Wallace JL, Boyd EF, Abebe KZ, Fried L, Palevsky PM, Conway PT, Liu KD, Parikh CR, Poggio Em Siew ED. Neyra JA, Weir MR, Wilson FP, Kane-Gill SL. Post-discharge care of AKI survivors: An opportunity for targeted nurse and pharmacist interventions. Adv Kidney Dis Health 2025;32:154-161. PMID: 40222802.
Justice CM 2nd, Nevin C, Neely RL, Dilcher B, Kovacic-Scherrer N, Carter-Templeton H, Ostrowski A, Krafcheck J, Smith G, McCarthy P, Pincavitch J, Kane-Gill S, Freeman R, Kellum JA, Kohli-Seth R, Nadkarni GN, Shawwa K, Sakhuja A. Effect of Tiered Implementation of Clinical Decision Support System for Acute Kidney Injury and Nephrotoxin Exposure in Cardiac Surgery Patients. Appl Clin Inform. 2025;16(1):1-10. PMID: 39742871.
Chapin MR, Kane-Gill SL, Li X, Abanyie K, Taneja SB, Egbert S, Paine MF, Boyce RD. Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System. Pharmacol Res Perspect 2025;13(1):e70047. PMID: 39719832.
Chapin MR, Kane-Gill SL, Li X, Abanyie K, Taneja SB, Egbert S, Paine MF, Boyce RD. Part 1: Evaluation of Pediatric Cannabis-Drug Interaction Reports. Pharmacol Res Perspect. 2025;13(1):e70046. PMID: 39719830.
Hernandez BN, Wieruszewski PM, Barreto JN, Cole KC, Damani S, Kane-Gill SL, Kashani KB, Kelly E, Rule AD, Teaford HR, Zand J, Barreto EF. Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance. Pharmacotherapy. 2024;44(12):898-906. PMID: 39601345; PMCID: PMC11693467.
White E, Kane-Gill SL, Jain S, Medico C, Ansani N, Coons JC. Utilizing Theoretical Domains Framework to Determine Barriers to Evidence-Based Recommendations in Non-Valvular Atrial Fibrillation. Ann Pharmacother. 2024:10600280241298947. Epub ahead of print. PMID: 3960014
Stottlemyer BA*, Tran T, Suh K, Kane-Gill SL. A systematic review of the costs of drug associated acute kidney injury and potential cost savings with prevention strategies. Clin Pharmacol Ther 2025;117:989-1004. PMID: 39535321.
Fernández-Llaneza D, Vos RMP, Lieverse JE, Gosselt HR, Kane-Gill SL, van Gelder T, Klopotowska JE; LEAPfROG Consortium. An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury. Drug Saf. 2025;48:43-58. PMID: 39327387.
Karimian A, Karimzadeh I, Shafiekhani M, Heidari R, Masjedi F, Izadi F, Barshan-Tashnizi N, Kane-Gill SL, Mahmoudi L. Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trial. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(3):2945-2960. PMID: 39311921.
Barreto EF, Gaggani AM, Hernandez BN, Amatullah N, Culley CM, Stottlemyer B, Murugan R, Ozrazgat-Baslanti T, Bihorac A, Kellum JA, Kashani KB, Rule AD, Kane-Gill SL; MEnD-AKI Study Group. The Acute Kidney Intervention and Pharmacotherapy (AKIP) List: Standardized List of Medications That Are Renally Eliminated and Nephrotoxic in the Acutely Ill. Ann Pharmacother. 2025;59(4):371-377. PMID: 39230007.
Saraiva IE, Hamahata N, Huang DT, Kane-Gill SL, Rivosecchi RM, Shiva S, Nolin TD, Chen X, Minturn J, Chang CH, Li X, Kellum J, Gómez H. Metformin for sepsis-associated AKI: a protocol for the Randomized Clinical Trial of the Safety and Feasibility of Metformin as a Treatment for sepsis-associated AKI (LiMiT AKI). BMJ Open. 2024 Apr 30;14(4):e081120. doi: 10.1136/bmjopen-2023-081120. PMID: 38688665; PMCID: PMC11086423.
June 5, 2025
Career Transitions, Roundtable Discussion
American Association of Colleges of Pharmacy Mid-Career Recharge Program
April 22, 2025
The Future of Antimicrobial Use in the ICU
Indonesia Society of Critical Care Medicine (virtual)
April 16, 2025
How to implement sedation best practices
Using AI in writing and research
4th Annual Egyptian Society of Anesthesiology and Acute Care (ESAAC) and 1st Afro-Arab Conference, Cairo, Egypt
March 27th, 2025
Motivating Factors for a Medication Safety Researcher
Northeastern University, Boston, MA
February 23, 2025
Joint SCCM/China Critical Care Society Session: Biomarkers in Sepsis Associated Acute Kidney Injury
The Goldilocks of Drug Dosing in AKI
54th Annual Congress SCCM, Orlando, FL
February 22, 2025
Critical Care and Beyond: How Critical Care Pharmacy Prepared Me for My Current Role
CCM CPP Pre-Congress Forum, 54th Annual Congress SCCM, Orlando, FL
February 4, 2025
Drug Dosing during RRT
Extracorporeal Organ Support Academy Webinar Series https://www.extracorporeal-organ.com/ecosacademy
December 8, 2024
Evolution of Excellence: Implementation of ICU Sedation Best Practices
ASHP 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA
November 29, 2024
This is Your Patient’s Kidneys on Drugs: Ensuring Recovery and Kidney Health
2nd Multidisciplinary Critical Care Rehabilitation Conference at Tallaght University Hospital, Dublin
November 14, 2024
Multicenter Implementation of an Electronic Decision Support System for Drug-Associated AKI (MEnD-AKI)
14th AKI Symposium, University of Pittsburgh, Pittsburgh, PA
October 31, 2024
Artificial Intelligence in Guideline Development and Clinical Practice
Contrast Associated AKI
Best of SCCM, Abu Dhabi UAE
October 12, 2024
Digging for Gold: Using real-time data to accelerate guideline updates
(AI)ming Higher: Artificial Intelligence in Frontline Clinical Practice and Technology in Guideline Development
American College of Clinical Pharmacy, Phoenix, Az
September 27, 2024
Rethinking our Current Thinking for Drug Related Kidney Diseases and Disorders
21st Annual New England Critical Care Pharmacotherapy Symposium, Boston, MA
August 16, 2024
Multicenter Implementation of an Electronic Decision Support System for Drug-Associated AKI (MEnD-AKI)
AI and Healthcare Symposium
Sponsored by the Pittsburgh Asian American Chamber of Commerce & Pittsburgh Biotechnology Board (https://vimeo.com/1004087476)
June 13-16, 2024
Nephrotoxin Stewardship and AKI Prevention
Asia Pacific Congress of Nephrology (APCN) & Korea Society of Nephrology (KSN), Seoul, South Korea
